Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide that seriously threatens human health. Chronic infection of hepatitis virus B, C and D is closely related to the occurrence of HCC, about 80% HCC cases are caused by chronic viral hepatitis. Effective antivir...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2023-01-01
|
| Series: | Gastroenterology & Endoscopy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949752322000012 |
| _version_ | 1797235496131231744 |
|---|---|
| author | Shuling Wu Liu Yang Xiaoyue Bi Yanjie Lin Wen Deng Tingting Jiang Minghui Li Yao Xie |
| author_facet | Shuling Wu Liu Yang Xiaoyue Bi Yanjie Lin Wen Deng Tingting Jiang Minghui Li Yao Xie |
| author_sort | Shuling Wu |
| collection | DOAJ |
| description | Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide that seriously threatens human health. Chronic infection of hepatitis virus B, C and D is closely related to the occurrence of HCC, about 80% HCC cases are caused by chronic viral hepatitis. Effective antiviral therapy can control liver inflammation, reduce the occurrence of HCC and reduce the recurrence of HCC after surgery treatment. In addition, during chemotherapy such as transarterial chemoembolization (TACE) or hepatic artery infusion chemotherapy (HAIC), targeted therapy and immunotherapy for HCC, antiviral therapy is also needed to prevent hepatitis virus reactivation. Therefore, antiviral therapy plays an important role in the prevention and treatment of HCC. |
| first_indexed | 2024-04-24T16:48:53Z |
| format | Article |
| id | doaj.art-dbee95fc88594a79b2bba0c8751c6143 |
| institution | Directory Open Access Journal |
| issn | 2949-7523 |
| language | English |
| last_indexed | 2024-04-24T16:48:53Z |
| publishDate | 2023-01-01 |
| publisher | KeAi Communications Co., Ltd. |
| record_format | Article |
| series | Gastroenterology & Endoscopy |
| spelling | doaj.art-dbee95fc88594a79b2bba0c8751c61432024-03-29T05:51:54ZengKeAi Communications Co., Ltd.Gastroenterology & Endoscopy2949-75232023-01-0111510Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virusShuling Wu0Liu Yang1Xiaoyue Bi2Yanjie Lin3Wen Deng4Tingting Jiang5Minghui Li6Yao Xie7Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, ChinaDepartment of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, 100015, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China; Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, 100015, China; Corresponding author. Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, No.8 Jingshun East Street, Chaoyang District, Beijing, 100015, China.Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China; Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, 100015, China; Corresponding author. Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, No.8 Jingshun East Street, Chaoyang District, Beijing, 100015, China.Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide that seriously threatens human health. Chronic infection of hepatitis virus B, C and D is closely related to the occurrence of HCC, about 80% HCC cases are caused by chronic viral hepatitis. Effective antiviral therapy can control liver inflammation, reduce the occurrence of HCC and reduce the recurrence of HCC after surgery treatment. In addition, during chemotherapy such as transarterial chemoembolization (TACE) or hepatic artery infusion chemotherapy (HAIC), targeted therapy and immunotherapy for HCC, antiviral therapy is also needed to prevent hepatitis virus reactivation. Therefore, antiviral therapy plays an important role in the prevention and treatment of HCC.http://www.sciencedirect.com/science/article/pii/S2949752322000012Hepatocellular carcinomaHepatitis virusAntiviral therapy |
| spellingShingle | Shuling Wu Liu Yang Xiaoyue Bi Yanjie Lin Wen Deng Tingting Jiang Minghui Li Yao Xie Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus Gastroenterology & Endoscopy Hepatocellular carcinoma Hepatitis virus Antiviral therapy |
| title | Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus |
| title_full | Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus |
| title_fullStr | Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus |
| title_full_unstemmed | Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus |
| title_short | Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus |
| title_sort | attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus |
| topic | Hepatocellular carcinoma Hepatitis virus Antiviral therapy |
| url | http://www.sciencedirect.com/science/article/pii/S2949752322000012 |
| work_keys_str_mv | AT shulingwu attachimportancetoantiviraltherapyinpatientswithhepatocellularcarcinomacausedbyhepatitisvirus AT liuyang attachimportancetoantiviraltherapyinpatientswithhepatocellularcarcinomacausedbyhepatitisvirus AT xiaoyuebi attachimportancetoantiviraltherapyinpatientswithhepatocellularcarcinomacausedbyhepatitisvirus AT yanjielin attachimportancetoantiviraltherapyinpatientswithhepatocellularcarcinomacausedbyhepatitisvirus AT wendeng attachimportancetoantiviraltherapyinpatientswithhepatocellularcarcinomacausedbyhepatitisvirus AT tingtingjiang attachimportancetoantiviraltherapyinpatientswithhepatocellularcarcinomacausedbyhepatitisvirus AT minghuili attachimportancetoantiviraltherapyinpatientswithhepatocellularcarcinomacausedbyhepatitisvirus AT yaoxie attachimportancetoantiviraltherapyinpatientswithhepatocellularcarcinomacausedbyhepatitisvirus |